Download PDF
Semin Plast Surg 2016; 30(02): 066-072
DOI: 10.1055/s-0036-1580730
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Orthopedic Prosthetic Infections: Diagnosis and Orthopedic Salvage

Matthew G. Kaufman
1   Division of Plastic and Reconstructive Surgery, Baylor College of Medicine, Houston, Texas
,
Jesse D. Meaike
1   Division of Plastic and Reconstructive Surgery, Baylor College of Medicine, Houston, Texas
,
Shayan A. Izaddoost
1   Division of Plastic and Reconstructive Surgery, Baylor College of Medicine, Houston, Texas
› Author Affiliations
Further Information

Publication History

Publication Date:
04 May 2016 (online)

    Permissions and Reprints

Abstract

Orthopedic hardware infections are much feared and costly complications that can occur when these devices are implemented both in traumatic cases as well as in joint replacement surgery. Because these infections can lead to great morbidity, it is important to understand their pathophysiology as well as the principles behind their diagnosis and initial treatment. Plastic surgeons are frequently consulted as part of a multidisciplinary team to provide stable soft tissue coverage of the associated defects that result from these infections. A review of the existing literature was performed to identify the potential causes of these infections, to provide established diagnostic criteria guidelines, and to explain how these prosthetic infections are managed from an orthopedic surgery perspective prior to consulting the plastic surgery team.

Keywords

orthopedic prosthetic infections - diagnosis - management
 

  • References

  • 1 Centers for Disease Control and Prevention. National Hospital Discharge Survey: 2010 table, procedures by selected patient characteristics - number by procedure category and age. Available at: http://www.cdc.gov/nchs/data/nhds/4procedures/2010pro4_numberprocedureage.pdf . Accessed February 27, 2016
    PubMedGoogle Scholar
  • 2 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (4) 780-785
    CrossrefPubMedGoogle Scholar
  • 3 Hernández-Vaquero D, Fernández-Fairen M, Torres A , et al. Treatment of periprosthetic infections: an economic analysis. ScientificWorldJournal 2013; 2013: 821650
    PubMedGoogle Scholar
  • 4 Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 2009; 91 (1) 128-133
    CrossrefPubMedGoogle Scholar
  • 5 Bozic KJ, Kurtz SM, Lau E , et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res 2010; 468 (1) 45-51
    CrossrefPubMedGoogle Scholar
  • 6 Bohm ER, Dunbar MJ, Frood JJ, Johnson TM, Morris KA. Rehospitalizations, early revisions, infections, and hospital resource use in the first year after hip and knee arthroplasties. J Arthroplasty 2012; 27 (2) 232-237.e1
    CrossrefPubMedGoogle Scholar
  • 7 Kurtz SM, Ong KL, Schmier J , et al. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am 2007; 89 (Suppl. 03) 144-151
    CrossrefPubMedGoogle Scholar
  • 8 Osmon DR, Berbari EF, Berendt AR , et al; Infectious Diseases Society of America. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013; 56 (1) e1-e25
    CrossrefPubMedGoogle Scholar
  • 9 Parvizi J, Gehrke T , Eds. Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection. 2013. Available at: http://www.msis-na.org/wp-content/themes/msis-temp/pdf/ism-periprosthetic-joint-information.pdf . Accessed February 27, 2016
    PubMedGoogle Scholar
  • 10 Parvizi J, Zmistowski B, Berbari EF , et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 2011; 469 (11) 2992-2994
    CrossrefPubMedGoogle Scholar
  • 11 Gusenoff JA, Hungerford DS, Orlando JC, Nahabedian MY. Outcome and management of infected wounds after total hip arthroplasty. Ann Plast Surg 2002; 49 (6) 587-592
    CrossrefPubMedGoogle Scholar
  • 12 Gbejuade HO, Lovering AM, Webb JC. The role of microbial biofilms in prosthetic joint infections. Acta Orthop 2015; 86 (2) 147-158
    CrossrefPubMedGoogle Scholar
  • 13 Panni AS, Vasso M, Cerciello S, Salgarello M. Wound complications in total knee arthroplasty. Which flap is to be used? With or without retention of prosthesis?. Knee Surg Sports Traumatol Arthrosc 2011; 19 (7) 1060-1068
    CrossrefPubMedGoogle Scholar
  • 14 Deva AK, Adams Jr WP, Vickery K. The role of bacterial biofilms in device-associated infection. Plast Reconstr Surg 2013; 132 (5) 1319-1328
    CrossrefPubMedGoogle Scholar
  • 15 Rezapoor M, Parvizi J. Prevention of Periprosthetic Joint Infection. J Arthroplasty 2015; 30 (6) 902-907
    CrossrefPubMedGoogle Scholar
  • 16 Der Tavitian J, Ong SM, Taub NA, Taylor GJ. Body-exhaust suit versus occlusive clothing. A randomised, prospective trial using air and wound bacterial counts. J Bone Joint Surg Br 2003; 85 (4) 490-494
    CrossrefPubMedGoogle Scholar
  • 17 Hooper GJ, Rothwell AG, Frampton C, Wyatt MC. Does the use of laminar flow and space suits reduce early deep infection after total hip and knee replacement?: the ten-year results of the New Zealand Joint Registry. J Bone Joint Surg Br 2011; 93 (1) 85-90
    CrossrefPubMedGoogle Scholar
  • 18 Kosins AM, Scholz T, Cetinkaya M, Evans GRD. Evidence-based value of subcutaneous surgical wound drainage: the largest systematic review and meta-analysis. Plast Reconstr Surg 2013; 132 (2) 443-450
    CrossrefPubMedGoogle Scholar
  • 19 American Academy of Orthopedic Surgeons. Antibiotic prophylaxis for patients after total joint replacement. Available at: http://orthodoc.aaos.org/davidgrimmmd/Antibiotic%20Prophylaxis%20for%20Patients%20after%20Total%20Joint%20Replacement.pdf . Accessed April 5, 2016
    PubMedGoogle Scholar
  • 20 Hall-Stoodley L, Stoodley P, Kathju S , et al. Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol 2012; 65 (2) 127-145
    CrossrefPubMedGoogle Scholar
  • 21 Stoodley P, Nistico L, Johnson S , et al. Direct demonstration of viable Staphylococcus aureus biofilms in an infected total joint arthroplasty. A case report. J Bone Joint Surg Am 2008; 90 (8) 1751-1758
    CrossrefPubMedGoogle Scholar
  • 22 Chen AF, Heller S, Parvizi J. Prosthetic joint infections. Surg Clin North Am 2014; 94 (6) 1265-1281
    CrossrefPubMedGoogle Scholar
  • 23 Suda AJ, Cieslik A, Grützner PA, Münzberg M, Heppert V. Flaps for closure of soft tissue defects in infected revision knee arthroplasty. Int Orthop 2014; 38 (7) 1387-1392
    CrossrefPubMedGoogle Scholar
  • 24 Viol A, Pradka SP, Baumeister SP , et al. Soft-tissue defects and exposed hardware: a review of indications for soft-tissue reconstruction and hardware preservation. Plast Reconstr Surg 2009; 123 (4) 1256-1263
    CrossrefPubMedGoogle Scholar
  • 25 Rightmire E, Zurakowski D, Vrahas M. Acute infections after fracture repair: management with hardware in place. Clin Orthop Relat Res 2008; 466 (2) 466-472
    CrossrefPubMedGoogle Scholar
  • 26 Berkes M, Obremskey WT, Scannell B, Ellington JK, Hymes RA, Bosse M ; Southeast Fracture Consortium. Maintenance of hardware after early postoperative infection following fracture internal fixation. J Bone Joint Surg Am 2010; 92 (4) 823-828
    CrossrefPubMedGoogle Scholar
  • 27 Lall RR, Wong AP, Lall RR, Lawton CD, Smith ZA, Dahdaleh NS. Evidence-based management of deep wound infection after spinal instrumentation. J Clin Neurosci 2015; 22 (2) 238-242
    CrossrefPubMedGoogle Scholar
  • 28 Cahill PJ, Warnick DE, Lee MJ , et al. Infection after spinal fusion for pediatric spinal deformity: thirty years of experience at a single institution. Spine 2010; 35 (12) 1211-1217
    Google Scholar
  • 29 Kowalski TJ, Berbari EF, Huddleston PM, Steckelberg JM, Mandrekar JN, Osmon DR. The management and outcome of spinal implant infections: contemporary retrospective cohort study. Clin Infect Dis 2007; 44 (7) 913-920
    CrossrefPubMedGoogle Scholar
  • 30 Maruo K, Berven SH. Outcome and treatment of postoperative spine surgical site infections: predictors of treatment success and failure. J Orthop Sci 2014; 19 (3) 398-404
    CrossrefPubMedGoogle Scholar
  • 31 Picada R, Winter RB, Lonstein JE , et al. Postoperative deep wound infection in adults after posterior lumbosacral spine fusion with instrumentation: incidence and management. J Spinal Disord 2000; 13 (1) 42-45
    Google Scholar
  • 32 Szöke G, Lipton G, Miller F, Dabney K. Wound infection after spinal fusion in children with cerebral palsy. J Pediatr Orthop 1998; 18 (6) 727-733
    PubMedGoogle Scholar
  • 33 Hedequist D, Haugen A, Hresko T, Emans J. Failure of attempted implant retention in spinal deformity delayed surgical site infections. Spine 2009; 34 (1) 60-64
    CrossrefPubMedGoogle Scholar
  • 34 Clark CE, Shufflebarger HL. Late-developing infection in instrumented idiopathic scoliosis. Spine 1999; 24 (18) 1909-1912
    CrossrefPubMedGoogle Scholar
  • 35 Raad I, Hanna H, Jiang Y , et al. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 2007; 51 (5) 1656-1660
    CrossrefPubMedGoogle Scholar
  • 36 John AK, Baldoni D, Haschke M , et al. Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob Agents Chemother 2009; 53 (7) 2719-2724
    CrossrefPubMedGoogle Scholar
  • 37 Trampuz A, Murphy CK, Rothstein DM, Widmer AF, Landmann R, Zimmerli W. Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection. Antimicrob Agents Chemother 2007; 51 (7) 2540-2545
    CrossrefPubMedGoogle Scholar
  • 38 Trampuz A, Zimmerli W. Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment. Drugs 2006; 66 (8) 1089-1105
    CrossrefPubMedGoogle Scholar